Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers

PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers

US Patent 10842785 · Granted Nov 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LOX enzyme inhibiting methods and compositions2024
Methods for chemically induced lineage reprogramming2024
Yeats inhibitors and methods of use thereof2022
PIM kinase inhibitors in combination with autophagy inhibitors for treatment of 2022
PIM kinase inhibitors in combination with autophagy inhibitors for treatment of 2022
Substituted pyrrolopyridines as ATR inhibitors2022
Compositions and methods for reprogramming non-neuronal cells into neuron-like c2020
PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for2020
PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for2020
PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for2020
Methods and systems for nucleic acid amplification2019
Crystalline free bases of C-Met inhibitor or crystalline acid salts thereof, and2019